CS-2374
- CAS号:1621175-65-2
- 英文名:GPR39-C3
- 中文名:CS-2374
- CBNumber:CB13126726
- 分子式:C18H19ClN6O2S
- 分子量:418.9
- MOL File:1621175-65-2.mol
- 沸点 :662.1±65.0 °C(Predicted)
- 密度 :1.462±0.06 g/cm3(Predicted)
- 储存条件 :2-8°C
- 溶解度 :DMSO:63.97(Max Conc. mg/mL);152.72(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:5):0.16(Max Conc. mg/mL);0.38(Max Conc. mM)
Ethanol:2.0(Max Conc. mg/mL);4.77(Max Conc. mM) - 形态 :A crystalline solid
- 酸度系数(pKa) :7.43±0.10(Predicted)
- 颜色 :White to off-white
CS-2374性质、用途与生产工艺
- 生物活性 TC-G-1008(GPR39-C3)是一种有效的、口服活性的 G-protein coupled receptor 39 (GPR39)(zinc receptor) 激动剂,对大鼠受体和人类受体的EC50值分别为0.4 nM 和0.8 nM。
-
靶点
Target Value rGPR39
(Cell-free assay)0.4 nM(EC50) hGPR39
(Cell-free assay)0.8 nM(EC50) -
体外研究
TC-G-1008 shows selectivity over a panel of kinases (IC 50 s>10 μM) and does not exhibit relevant binding affinity for the related ghrelin and neurotensin-1 receptors (IC 50 s>30 μM). In HEK293-GPR39 cells, GPR39-C3, which is a positive allosteric modulator, activates cAMP production (downstream of Gs), IP1 accumulation (downstream of Gq), SRF-RE-dependent transcription (downstream of G12/13), and β-arrestin recruitment. GPR39-C3 induces dose- and time-dependent loss of response in cAMP production by second challenge of the compound.
-
体内研究
Rat and mouse plasma protein binding for TC-G-1008 is measured as 99.3% and 99.1%, respectively. TC-G-1008 is orally bioavailable in mice and robustly induces acute GLP-1 levels. Upon single oral doses of 10, 30, and 100 mg/kg of aqueous suspensions in 0.5% methylcellulose/0.1% Tween 80, TC-G-1008 achieves, between 1 and 1.5 h, maximal exposures of 1.4, 6.1, and 25.3 μM, respectively.
- 更新日期:2025/02/05
- 产品编号:HY-103007
- 产品名称:TC-G-1008
- CAS编号:1621175-65-2
- 包装:1 mg
- 价格:500元
- 更新日期:2025/02/05
- 产品编号:HY-103007
- 产品名称:CS-2374 TC-G-1008
- CAS编号:1621175-65-2
- 包装:5mg
- 价格:1100元
- 公司名称:TOCRIS-US
- 联系电话:--
- 电子邮件:customerservice@tocris.co.uk
- 国家:英国
- 产品数:5726
- 优势度:77